Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit

Introduction. Invasive meningococcal disease (IMD) is a serious infectious disease requiring stay in a pediatric intensive care unit (PICU) that continues to be associated with high morbidity and mortality rates. Prompt recognition, early antibiotic therapy, and aggressive supportive therapies can r...

Full description

Saved in:
Bibliographic Details
Main Authors: Eylem Kiral, Ayse Filiz Yetimakman
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/9713918
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560666403143680
author Eylem Kiral
Ayse Filiz Yetimakman
author_facet Eylem Kiral
Ayse Filiz Yetimakman
author_sort Eylem Kiral
collection DOAJ
description Introduction. Invasive meningococcal disease (IMD) is a serious infectious disease requiring stay in a pediatric intensive care unit (PICU) that continues to be associated with high morbidity and mortality rates. Prompt recognition, early antibiotic therapy, and aggressive supportive therapies can reduce mortality. We aimed to assess the clinical and laboratory characteristics of children with IMD. Patients and Methods. We retrospectively evaluated the medical records of 12 children with IMD requiring PICU stay between January 2018 and July 2019. Results. We followed up 12 patients (five girls and seven boys, 5–168 months of age, and four below one year of age) with IMD (nine patients have meningococcemia with meningitis, and three patients have meningococcemia) in PICU. All children were previously healthy and have not received meningococcal vaccines. Their pediatric risk of mortality (PRISM) scores varies between 5 and 37, four of the patients required mechanical ventilation, and the predicted mortality was 39% at admission. Seven patients had catecholamine refractory septic shock and disseminated intravascular coagulation (DIC). Three of the patients required extracorporeal treatment. The predominant serogroup is Men B (5/12). The mortality rate was 16.6% with early use of antibiotics, fluids, and other interventions. Conclusion. Mortality related to IMD is higher among children with severe meningococcemia despite early interventions in PICU. Routine use of meningococcal vaccines during childhood would be a better strategy for controlling IMD in both developing and developed countries.
format Article
id doaj-art-583bb96c15914578a2cca1276516cfe1
institution Kabale University
issn 2090-1305
2090-1313
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Critical Care Research and Practice
spelling doaj-art-583bb96c15914578a2cca1276516cfe12025-02-03T01:26:58ZengWileyCritical Care Research and Practice2090-13052090-13132021-01-01202110.1155/2021/97139189713918Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care UnitEylem Kiral0Ayse Filiz Yetimakman1Department of Pediatric Intensive Care, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir 26040, TurkeyDepartment of Pediatric Intensive Care, Kocaeli University Faculty of Medicine, Umuttepe, Izmit 41001, TurkeyIntroduction. Invasive meningococcal disease (IMD) is a serious infectious disease requiring stay in a pediatric intensive care unit (PICU) that continues to be associated with high morbidity and mortality rates. Prompt recognition, early antibiotic therapy, and aggressive supportive therapies can reduce mortality. We aimed to assess the clinical and laboratory characteristics of children with IMD. Patients and Methods. We retrospectively evaluated the medical records of 12 children with IMD requiring PICU stay between January 2018 and July 2019. Results. We followed up 12 patients (five girls and seven boys, 5–168 months of age, and four below one year of age) with IMD (nine patients have meningococcemia with meningitis, and three patients have meningococcemia) in PICU. All children were previously healthy and have not received meningococcal vaccines. Their pediatric risk of mortality (PRISM) scores varies between 5 and 37, four of the patients required mechanical ventilation, and the predicted mortality was 39% at admission. Seven patients had catecholamine refractory septic shock and disseminated intravascular coagulation (DIC). Three of the patients required extracorporeal treatment. The predominant serogroup is Men B (5/12). The mortality rate was 16.6% with early use of antibiotics, fluids, and other interventions. Conclusion. Mortality related to IMD is higher among children with severe meningococcemia despite early interventions in PICU. Routine use of meningococcal vaccines during childhood would be a better strategy for controlling IMD in both developing and developed countries.http://dx.doi.org/10.1155/2021/9713918
spellingShingle Eylem Kiral
Ayse Filiz Yetimakman
Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit
Critical Care Research and Practice
title Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit
title_full Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit
title_fullStr Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit
title_full_unstemmed Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit
title_short Clinical and Laboratory Findings of 12 Children with Invasive Meningococcal Disease in Pediatric Intensive Care Unit
title_sort clinical and laboratory findings of 12 children with invasive meningococcal disease in pediatric intensive care unit
url http://dx.doi.org/10.1155/2021/9713918
work_keys_str_mv AT eylemkiral clinicalandlaboratoryfindingsof12childrenwithinvasivemeningococcaldiseaseinpediatricintensivecareunit
AT aysefilizyetimakman clinicalandlaboratoryfindingsof12childrenwithinvasivemeningococcaldiseaseinpediatricintensivecareunit